Filtered By:
Specialty: Biomedical Science

This page shows you your search results in order of date. This is page number 14.

Order by Relevance | Date

Total 5325 results found since Jan 2013.

Trends of humoral immune responses to heterologous antigenic exposure due to vaccination & amp; omicron SARS-CoV-2 infection: Implications for boosting
CONCLUSIONS: Anti-RBD IgG antibodies were detected in 85 per cent of participants after a median gap of eight months following the second vaccine dose. Omicron infection probably resulted in a substantial proportion of asymptomatic infection in the first four months in our study population and boosted the vaccine-induced humoral immune response, which declined but still remained durable over 10 months.PMID:37322634 | DOI:10.4103/ijmr.ijmr_2521_22
Source: The Indian Journal of Medical Research - June 16, 2023 Category: Biomedical Science Authors: Gaurav Batra Deepika Rathna Murugesan Sreevatsan Raghavan Souvick Chattopadhyay Farha Mehdi None Ayushi Mudita Gosain Savita Singh Soon Jyoti Das Suprit Deshpande Sudipta Sonar Kamini Jakhar Jayanta Bhattacharya Shailendra Mani Anil Kumar Pandey None Sank Source Type: research

Risk factors for clinically significant diffuse parenchymal lung abnormalities persisting after severe COVID-19 pneumonia
CONCLUSIONS: Longer hospital stay was observed to be the only independent predictor of CS-DPLA six months after severe COVID-19. Serum TGF-β should be evaluated further as a biomarker.PMID:37322633 | DOI:10.4103/ijmr.ijmr_2360_22
Source: The Indian Journal of Medical Research - June 16, 2023 Category: Biomedical Science Authors: Sahajal Dhooria Siddhant Arora Shivani Chaudhary Inderpaul Singh Sehgal Nidhi Prabhakar Nasim Mohammad Riya Sharma Prabir Das Yashwant Kumar Mandeep Garg Goverdhan Dutt Puri Ashish Bhalla Valliappan Muthu Kuruswamy Thurai Prasad Ritesh Agarwal Ashutosh Na Source Type: research

Trends of humoral immune responses to heterologous antigenic exposure due to vaccination & amp; omicron SARS-CoV-2 infection: Implications for boosting
CONCLUSIONS: Anti-RBD IgG antibodies were detected in 85 per cent of participants after a median gap of eight months following the second vaccine dose. Omicron infection probably resulted in a substantial proportion of asymptomatic infection in the first four months in our study population and boosted the vaccine-induced humoral immune response, which declined but still remained durable over 10 months.PMID:37322634 | DOI:10.4103/ijmr.ijmr_2521_22
Source: The Indian Journal of Medical Research - June 16, 2023 Category: Biomedical Science Authors: Gaurav Batra Deepika Rathna Murugesan Sreevatsan Raghavan Souvick Chattopadhyay Farha Mehdi None Ayushi Mudita Gosain Savita Singh Soon Jyoti Das Suprit Deshpande Sudipta Sonar Kamini Jakhar Jayanta Bhattacharya Shailendra Mani Anil Kumar Pandey None Sank Source Type: research

Risk factors for clinically significant diffuse parenchymal lung abnormalities persisting after severe COVID-19 pneumonia
CONCLUSIONS: Longer hospital stay was observed to be the only independent predictor of CS-DPLA six months after severe COVID-19. Serum TGF-β should be evaluated further as a biomarker.PMID:37322633 | DOI:10.4103/ijmr.ijmr_2360_22
Source: The Indian Journal of Medical Research - June 16, 2023 Category: Biomedical Science Authors: Sahajal Dhooria Siddhant Arora Shivani Chaudhary Inderpaul Singh Sehgal Nidhi Prabhakar Nasim Mohammad Riya Sharma Prabir Das Yashwant Kumar Mandeep Garg Goverdhan Dutt Puri Ashish Bhalla Valliappan Muthu Kuruswamy Thurai Prasad Ritesh Agarwal Ashutosh Na Source Type: research

Trends of humoral immune responses to heterologous antigenic exposure due to vaccination & amp; omicron SARS-CoV-2 infection: Implications for boosting
CONCLUSIONS: Anti-RBD IgG antibodies were detected in 85 per cent of participants after a median gap of eight months following the second vaccine dose. Omicron infection probably resulted in a substantial proportion of asymptomatic infection in the first four months in our study population and boosted the vaccine-induced humoral immune response, which declined but still remained durable over 10 months.PMID:37322634 | DOI:10.4103/ijmr.ijmr_2521_22
Source: The Indian Journal of Medical Research - June 16, 2023 Category: Biomedical Science Authors: Gaurav Batra Deepika Rathna Murugesan Sreevatsan Raghavan Souvick Chattopadhyay Farha Mehdi None Ayushi Mudita Gosain Savita Singh Soon Jyoti Das Suprit Deshpande Sudipta Sonar Kamini Jakhar Jayanta Bhattacharya Shailendra Mani Anil Kumar Pandey None Sank Source Type: research

Risk factors for clinically significant diffuse parenchymal lung abnormalities persisting after severe COVID-19 pneumonia
CONCLUSIONS: Longer hospital stay was observed to be the only independent predictor of CS-DPLA six months after severe COVID-19. Serum TGF-β should be evaluated further as a biomarker.PMID:37322633 | DOI:10.4103/ijmr.ijmr_2360_22
Source: The Indian Journal of Medical Research - June 16, 2023 Category: Biomedical Science Authors: Sahajal Dhooria Siddhant Arora Shivani Chaudhary Inderpaul Singh Sehgal Nidhi Prabhakar Nasim Mohammad Riya Sharma Prabir Das Yashwant Kumar Mandeep Garg Goverdhan Dutt Puri Ashish Bhalla Valliappan Muthu Kuruswamy Thurai Prasad Ritesh Agarwal Ashutosh Na Source Type: research

Trends of humoral immune responses to heterologous antigenic exposure due to vaccination & amp; omicron SARS-CoV-2 infection: Implications for boosting
CONCLUSIONS: Anti-RBD IgG antibodies were detected in 85 per cent of participants after a median gap of eight months following the second vaccine dose. Omicron infection probably resulted in a substantial proportion of asymptomatic infection in the first four months in our study population and boosted the vaccine-induced humoral immune response, which declined but still remained durable over 10 months.PMID:37322634 | DOI:10.4103/ijmr.ijmr_2521_22
Source: The Indian Journal of Medical Research - June 16, 2023 Category: Biomedical Science Authors: Gaurav Batra Deepika Rathna Murugesan Sreevatsan Raghavan Souvick Chattopadhyay Farha Mehdi None Ayushi Mudita Gosain Savita Singh Soon Jyoti Das Suprit Deshpande Sudipta Sonar Kamini Jakhar Jayanta Bhattacharya Shailendra Mani Anil Kumar Pandey None Sank Source Type: research

Risk factors for clinically significant diffuse parenchymal lung abnormalities persisting after severe COVID-19 pneumonia
CONCLUSIONS: Longer hospital stay was observed to be the only independent predictor of CS-DPLA six months after severe COVID-19. Serum TGF-β should be evaluated further as a biomarker.PMID:37322633 | DOI:10.4103/ijmr.ijmr_2360_22
Source: The Indian Journal of Medical Research - June 16, 2023 Category: Biomedical Science Authors: Sahajal Dhooria Siddhant Arora Shivani Chaudhary Inderpaul Singh Sehgal Nidhi Prabhakar Nasim Mohammad Riya Sharma Prabir Das Yashwant Kumar Mandeep Garg Goverdhan Dutt Puri Ashish Bhalla Valliappan Muthu Kuruswamy Thurai Prasad Ritesh Agarwal Ashutosh Na Source Type: research

Trends of humoral immune responses to heterologous antigenic exposure due to vaccination & amp; omicron SARS-CoV-2 infection: Implications for boosting
CONCLUSIONS: Anti-RBD IgG antibodies were detected in 85 per cent of participants after a median gap of eight months following the second vaccine dose. Omicron infection probably resulted in a substantial proportion of asymptomatic infection in the first four months in our study population and boosted the vaccine-induced humoral immune response, which declined but still remained durable over 10 months.PMID:37322634 | DOI:10.4103/ijmr.ijmr_2521_22
Source: The Indian Journal of Medical Research - June 16, 2023 Category: Biomedical Science Authors: Gaurav Batra Deepika Rathna Murugesan Sreevatsan Raghavan Souvick Chattopadhyay Farha Mehdi None Ayushi Mudita Gosain Savita Singh Soon Jyoti Das Suprit Deshpande Sudipta Sonar Kamini Jakhar Jayanta Bhattacharya Shailendra Mani Anil Kumar Pandey None Sank Source Type: research

Risk factors for clinically significant diffuse parenchymal lung abnormalities persisting after severe COVID-19 pneumonia
CONCLUSIONS: Longer hospital stay was observed to be the only independent predictor of CS-DPLA six months after severe COVID-19. Serum TGF-β should be evaluated further as a biomarker.PMID:37322633 | DOI:10.4103/ijmr.ijmr_2360_22
Source: The Indian Journal of Medical Research - June 16, 2023 Category: Biomedical Science Authors: Sahajal Dhooria Siddhant Arora Shivani Chaudhary Inderpaul Singh Sehgal Nidhi Prabhakar Nasim Mohammad Riya Sharma Prabir Das Yashwant Kumar Mandeep Garg Goverdhan Dutt Puri Ashish Bhalla Valliappan Muthu Kuruswamy Thurai Prasad Ritesh Agarwal Ashutosh Na Source Type: research

Trends of humoral immune responses to heterologous antigenic exposure due to vaccination & amp; omicron SARS-CoV-2 infection: Implications for boosting
CONCLUSIONS: Anti-RBD IgG antibodies were detected in 85 per cent of participants after a median gap of eight months following the second vaccine dose. Omicron infection probably resulted in a substantial proportion of asymptomatic infection in the first four months in our study population and boosted the vaccine-induced humoral immune response, which declined but still remained durable over 10 months.PMID:37322634 | DOI:10.4103/ijmr.ijmr_2521_22
Source: The Indian Journal of Medical Research - June 16, 2023 Category: Biomedical Science Authors: Gaurav Batra Deepika Rathna Murugesan Sreevatsan Raghavan Souvick Chattopadhyay Farha Mehdi None Ayushi Mudita Gosain Savita Singh Soon Jyoti Das Suprit Deshpande Sudipta Sonar Kamini Jakhar Jayanta Bhattacharya Shailendra Mani Anil Kumar Pandey None Sank Source Type: research

Risk factors for clinically significant diffuse parenchymal lung abnormalities persisting after severe COVID-19 pneumonia
CONCLUSIONS: Longer hospital stay was observed to be the only independent predictor of CS-DPLA six months after severe COVID-19. Serum TGF-β should be evaluated further as a biomarker.PMID:37322633 | DOI:10.4103/ijmr.ijmr_2360_22
Source: The Indian Journal of Medical Research - June 16, 2023 Category: Biomedical Science Authors: Sahajal Dhooria Siddhant Arora Shivani Chaudhary Inderpaul Singh Sehgal Nidhi Prabhakar Nasim Mohammad Riya Sharma Prabir Das Yashwant Kumar Mandeep Garg Goverdhan Dutt Puri Ashish Bhalla Valliappan Muthu Kuruswamy Thurai Prasad Ritesh Agarwal Ashutosh Na Source Type: research

Trends of humoral immune responses to heterologous antigenic exposure due to vaccination & amp; omicron SARS-CoV-2 infection: Implications for boosting
CONCLUSIONS: Anti-RBD IgG antibodies were detected in 85 per cent of participants after a median gap of eight months following the second vaccine dose. Omicron infection probably resulted in a substantial proportion of asymptomatic infection in the first four months in our study population and boosted the vaccine-induced humoral immune response, which declined but still remained durable over 10 months.PMID:37322634 | DOI:10.4103/ijmr.ijmr_2521_22
Source: The Indian Journal of Medical Research - June 16, 2023 Category: Biomedical Science Authors: Gaurav Batra Deepika Rathna Murugesan Sreevatsan Raghavan Souvick Chattopadhyay Farha Mehdi None Ayushi Mudita Gosain Savita Singh Soon Jyoti Das Suprit Deshpande Sudipta Sonar Kamini Jakhar Jayanta Bhattacharya Shailendra Mani Anil Kumar Pandey None Sank Source Type: research

Risk factors for clinically significant diffuse parenchymal lung abnormalities persisting after severe COVID-19 pneumonia
CONCLUSIONS: Longer hospital stay was observed to be the only independent predictor of CS-DPLA six months after severe COVID-19. Serum TGF-β should be evaluated further as a biomarker.PMID:37322633 | DOI:10.4103/ijmr.ijmr_2360_22
Source: The Indian Journal of Medical Research - June 16, 2023 Category: Biomedical Science Authors: Sahajal Dhooria Siddhant Arora Shivani Chaudhary Inderpaul Singh Sehgal Nidhi Prabhakar Nasim Mohammad Riya Sharma Prabir Das Yashwant Kumar Mandeep Garg Goverdhan Dutt Puri Ashish Bhalla Valliappan Muthu Kuruswamy Thurai Prasad Ritesh Agarwal Ashutosh Na Source Type: research